Relicus was created with a vision to change the way we see healthcare, shifting the focus from disease management to lifestyle management, from fixing the problems to preventing them, and we are dogged in our pursuit to make this new paradigm the new standard.
In addition to redefining what it means to be healthy, what it means to live well, Relicus is also doing something that’s never been done before—building a vibrant conglomerate of exceptional, integrative practices in the anti-aging and age management spaces. While consolidation is common in other industries, Relicus’ effort to bring together the best in functional medicine is both unmatched and unprecedented.
What’s more, Relicus stands apart not only in our mission but in what we bring to the realization of that mission. Our world-class board of directors, led by Mr. Daniel S. Pena, delivers decades of experience in acquisition expertise and operational excellence, as well as an astonishing breadth and depth of corporate skill, for a leadership team that is second-to-none.
Relicus was incorporated on December 31, 2021, at the precipice of a new year filled with new opportunity, but its formation has been years in the making. Founder Dr. John A. Robinson’s passion for age management and natural health reaches back more than 30 years and has guided him through medical school and private practice to the concept of Relicus. It was then through the mentorship, personal development, and business acumen Dr. Robinson received from Mr. Pena, whom he met in 2018, that Relicus came to fruition, built on a revolutionary vision and a remarkable Board of incomparable professionals.
While Relicus embraces its role as the catalyst to a new way forward in medicine, we remain deeply rooted in our commitment to quality, integrative patient care. Longevity, age management, and natural wellness remain at the heart of all we do and continue to inform our philosophical approach to improving people’s lives.
To rapidly build a vibrant nationwide network of retail health medical practices and companies in the wellness, longevity, and age management medicine spheres through proved M & A strategies that deliver seamless patient experiences, optimize operations, produce maximum value, and create massive equity.
Our vision is stronger when we share it. We pursue and nurture collaborative partnerships with practices who are passionate about patient care, where innovation thrives and advance treatments are the standard. We leverage our resources to emphasize patient choice, cost management, and tailored solutions so physicians can continue delivering exceptional, leading-edge patient care for superior outcomes.
We know how to close the deal and we know how to deliver returns. We believe that a company’s true worth is more than the sum of its parts, and that the success of one drives the success of all. We increase profitability and future-proof businesses for long-term growth by reducing redundant operations, producing efficiency savings, maximizing price buying power, and providing physician training and leadership.
There is no shortcut for experience and no single algorithm for success. Our diverse and highly skilled hard of directors combines proved strategic business practices with intangibles of enormous value. We’re proud of our incomparable breadth and depth of industry-leading experience in healthcare operations, M & A transactions, scalability, marketing, and fiduciary practice that collectively spans more than 200 years, and we know what it takes to achieve greatness.
We will lead the Wellness and Longevity Medicine Market and Retail Health industry in the successful and vigorous consolidation of interactive health and anti-aging practices to redefine the future of healthcare from disease management to lifestyle optimization and to capture untapped market value.
Our value proposition is more than unique- it is singular and unprecedented. Currently, Relicus stands apart as the only company, past or present, to consolidate integrative practices in the anti-aging space. As such, we can offer opportunities to physicians, practices, and investors that are simply unmatched in functional medicine.
Relicus is positioned for accelerated expansion via our two-pronged M & A approach in which we:
We anticipate rapid growth through acquisition to $100 million within the next 5 years.
Our acquisition process delivers maximum value to owners, principals, and partner shareholders involved in every transaction with:
